195 related articles for article (PubMed ID: 26045764)
41. Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.
Gitau SC; Li X; Zhao D; Guo Z; Liang H; Qian M; Lv L; Li T; Xu B; Wang Z; Zhang Y; Xu C; Lu Y; Du Z; Shan H; Yang B
Front Med; 2015 Dec; 9(4):444-56. PubMed ID: 26626190
[TBL] [Abstract][Full Text] [Related]
42. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
43. microRNA-10a Targets T-box 5 to Inhibit the Development of Cardiac Hypertrophy.
Wang D; Zhai G; Ji Y; Jing H
Int Heart J; 2017 Feb; 58(1):100-106. PubMed ID: 28100873
[TBL] [Abstract][Full Text] [Related]
44. Unraveling the Expression Profiles of Long Noncoding RNAs in Rat Cardiac Hypertrophy and Functions of lncRNA BC088254 in Cardiac Hypertrophy Induced by Transverse Aortic Constriction.
Li X; Zhang L; Liang J
Cardiology; 2016; 134(2):84-98. PubMed ID: 26919297
[TBL] [Abstract][Full Text] [Related]
45. Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice.
Hu ZQ; Luo JF; Yu XJ; Zhu JN; Huang L; Yang J; Fu YH; Li T; Xue YM; Feng YQ; Shan ZX
Oncotarget; 2017 Nov; 8(54):92079-92089. PubMed ID: 29190899
[TBL] [Abstract][Full Text] [Related]
46. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
[TBL] [Abstract][Full Text] [Related]
47. Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
Yang R; Li L; Hou Y; Li Y; Zhang J; Yang N; Zhang Y; Ji W; Yu T; Lv L; Liang H; Li X; Li T; Shan H
Cell Death Dis; 2023 May; 14(5):344. PubMed ID: 37253771
[TBL] [Abstract][Full Text] [Related]
48. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
49. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
50. [Preliminary Study of Necroptosis in Cardiac Hypertrophy Induced by Pressure Overload].
Zhao M; Qin Y; Lu L; Tang X; Wu W; Fu H; Liu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):618-23. PubMed ID: 26485988
[TBL] [Abstract][Full Text] [Related]
51. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
[TBL] [Abstract][Full Text] [Related]
52. STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis.
Zhang J; Liang Y; Huang X; Guo X; Liu Y; Zhong J; Yuan J
Sci Rep; 2019 Jan; 9(1):460. PubMed ID: 30679521
[TBL] [Abstract][Full Text] [Related]
53. Propranolol causes a paradoxical enhancement of cardiomyocyte foetal gene response to hypertrophic stimuli.
Patrizio M; Musumeci M; Stati T; Fasanaro P; Palazzesi S; Catalano L; Marano G
Br J Pharmacol; 2007 Sep; 152(2):216-22. PubMed ID: 17592507
[TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA Chast promotes cardiac remodeling.
Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
56. Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy.
Ito S; Asakura M; Liao Y; Min KD; Takahashi A; Shindo K; Yamazaki S; Tsukamoto O; Asanuma H; Mogi M; Horiuchi M; Asano Y; Sanada S; Minamino T; Takashima S; Mochizuki N; Kitakaze M
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385424
[TBL] [Abstract][Full Text] [Related]
57. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
Hoepfner J; Leonardy J; Lu D; Schmidt K; Hunkler HJ; Biß S; Foinquinos A; Xiao K; Regalla K; Ramanujam D; Engelhardt S; Bär C; Thum T
Mol Ther; 2022 Mar; 30(3):1265-1274. PubMed ID: 34856383
[TBL] [Abstract][Full Text] [Related]
58. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
59. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
60. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
Cannon MV; Yu H; Candido WM; Dokter MM; Lindstedt EL; Silljé HH; van Gilst WH; de Boer RA
Eur J Heart Fail; 2015 Mar; 17(3):273-82. PubMed ID: 25684370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
